Lifeblood receives post-donation information with relevance to recipient safety including:
- the diagnosis of a potential transfusion-transmissible infection (TTI) in a donor via internal or external testing
- a clinical history suggestive of a potential TTI in a donor
- a donor reporting a previously undisclosed risk factor for a TTI that occurred prior to donation, and
- a donor reporting a previously undisclosed teratogenic medication or vaccination that was administered prior to a donation.
When fresh blood components presenting a significantly increased risk of harm to the recipient have been transfused, Lifeblood has a duty of care to notify the patient’s clinician.
It is the clinician's decision to notify the transfused recipient and- determine what actions, if any, to perform for their patient. Lifeblood can provide advice if needed for specific circumstances.